A detailed history of Gemmer Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Gemmer Asset Management LLC holds 2,510 shares of ABBV stock, worth $500,745. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,510
Previous 2,616 4.05%
Holding current value
$500,745
Previous $448,000 10.49%
% of portfolio
0.05%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$163.84 - $199.33 $17,367 - $21,128
-106 Reduced 4.05%
2,510 $495,000
Q2 2024

Jul 15, 2024

BUY
$154.79 - $180.76 $154 - $180
1 Added 0.04%
2,616 $448,000
Q1 2024

Apr 23, 2024

SELL
$159.82 - $182.1 $11,347 - $12,929
-71 Reduced 2.64%
2,615 $476,000
Q4 2023

Jan 17, 2024

BUY
$137.6 - $154.97 $7,568 - $8,523
55 Added 2.09%
2,686 $416,000
Q3 2023

Oct 18, 2023

SELL
$133.59 - $154.65 $44,886 - $51,962
-336 Reduced 11.32%
2,631 $392,000
Q2 2023

Jul 19, 2023

SELL
$132.51 - $164.9 $178,225 - $221,790
-1,345 Reduced 31.19%
2,967 $399,000
Q1 2023

Apr 17, 2023

BUY
$144.61 - $166.54 $23,282 - $26,812
161 Added 3.88%
4,312 $687,000
Q4 2022

Jan 20, 2023

BUY
$138.31 - $165.87 $15,905 - $19,075
115 Added 2.85%
4,151 $0
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $2,013 - $2,308
15 Added 0.37%
4,036 $542,000
Q2 2022

Jul 22, 2022

BUY
$137.62 - $174.96 $2,477 - $3,149
18 Added 0.45%
4,021 $616,000
Q1 2022

Apr 20, 2022

SELL
$131.98 - $163.75 $2,111 - $2,620
-16 Reduced 0.4%
4,003 $648,000
Q4 2021

Jan 21, 2022

BUY
$107.43 - $135.93 $30,187 - $38,196
281 Added 7.52%
4,019 $544,000
Q3 2021

Oct 19, 2021

SELL
$106.4 - $120.78 $16,811 - $19,083
-158 Reduced 4.06%
3,738 $403,000
Q2 2021

Jul 23, 2021

BUY
$105.21 - $117.21 $4,524 - $5,040
43 Added 1.12%
3,896 $439,000
Q1 2021

Apr 20, 2021

BUY
$102.3 - $112.62 $160,508 - $176,700
1,569 Added 68.7%
3,853 $417,000
Q4 2020

Jan 28, 2021

SELL
$80.49 - $108.67 $7,807 - $10,540
-97 Reduced 4.07%
2,284 $245,000
Q2 2020

Jul 31, 2020

SELL
$73.37 - $98.18 $4,035 - $5,399
-55 Reduced 2.26%
2,381 $234,000
Q1 2020

May 01, 2020

BUY
$64.5 - $97.79 $11,158 - $16,917
173 Added 7.64%
2,436 $185,000
Q4 2019

Jan 17, 2020

SELL
$72.13 - $90.25 $5,265 - $6,588
-73 Reduced 3.13%
2,263 $200,000
Q3 2019

Oct 11, 2019

BUY
$62.98 - $75.72 $6,109 - $7,344
97 Added 4.33%
2,336 $177,000
Q2 2019

Jul 18, 2019

SELL
$65.7 - $83.98 $97,761 - $124,962
-1,488 Reduced 39.92%
2,239 $163,000
Q1 2019

Apr 17, 2019

SELL
$77.14 - $90.79 $771 - $907
-10 Reduced 0.27%
3,727 $300,000
Q4 2018

Jan 18, 2019

BUY
$77.85 - $96.01 $856 - $1,056
11 Added 0.3%
3,737 $345,000
Q3 2018

Oct 12, 2018

SELL
$88.91 - $98.84 $28,184 - $31,332
-317 Reduced 7.84%
3,726 $352,000
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $9,201 - $12,321
-100 Reduced 2.41%
4,043 $383,000
Q4 2017

Jan 16, 2018

BUY
$89.56 - $98.21 $17,912 - $19,642
200 Added 5.07%
4,143 $401,000
Q3 2017

Oct 12, 2017

BUY
$69.85 - $89.22 $275,418 - $351,794
3,943
3,943 $350,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $353B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Gemmer Asset Management LLC Portfolio

Follow Gemmer Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gemmer Asset Management LLC with notifications on news.